Cancer Immunoprevention: Current Status and Future Directions

Area of Science:

• Oncology
• Immunology
• Cancer Prevention

Background:

• Cancer remains a leading cause of death globally, with limited improvements in patient survival despite various therapies.
• Early detection of premalignant lesions and their prevention are vital for reducing cancer morbidity and mortality.
• Cancer immunoprevention, leveraging the tumor-immune system interplay, is a promising approach.

Purpose of the Study:

• To provide a comprehensive review of cancer immunoprevention from basic science to clinical application.
• To elucidate the dual role of the immune system in tumor suppression and promotion.
• To discuss the progress in developing preventive strategies against various cancers.

Main Methods:

• Review of existing literature on tumor immunology and cancer prevention.
• Analysis of the mechanisms underlying virally-induced cancer immunoprevention.
• Examination of tumor antigen identification in premalignant lesions.
• Assessment of clinical advancements in cancer immunoprevention therapies.

Main Results:

• The immune system plays a complex role in both suppressing and promoting tumor development.
• Successful immunoprevention of virally-induced cancers provides a model for broader applications.
• Identification of tumor antigens in premalignant lesions enables the design of targeted preventive vaccines.
• Emerging strategies include preventive vaccines, immune checkpoint inhibitors, and immunomodulators like imiquimod.

Conclusions:

• Cancer immunoprevention offers a vital strategy to combat cancer by harnessing the immune system.
• Advances in understanding tumor antigens and immune responses are driving the development of novel preventive vaccines and therapies.
• Further research and clinical translation are essential for realizing the full potential of cancer immunoprevention.